Neurocrine Bio. (NBIX) PT Raised to $189 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Corinne Johnson raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $189.00 (from $188.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
